BTC Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
Other funds holding ANIP
SCM
TCM
GACM
BTC Capital Management's ANIP Position: Q2 2026 in Review
BTC Capital Management increased its ANI Pharmaceuticals (ANIP) stake by 3.4% in Q2 2026, buying an estimated $22.2K and bringing the position to 8,414 shares worth $697K. The position accounts for 0.04% of the portfolio, ranked #160.
BTC Capital Management first reported a position in ANIP in Q4 2021 and has held it in 15 quarters since. The position peaked at $702K in Q3 2025. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.
- BTC Capital Management held 8,414 shares of ANI Pharmaceuticals worth $697K as of Q2 2026.
- BTC Capital Management bought 277 ANI Pharmaceuticals shares in Q2 2026, an estimated $22.2K.
- ANI Pharmaceuticals made up 0.04% of BTC Capital Management's portfolio in Q2 2026, its #160 holding.
- BTC Capital Management first reported a position in ANI Pharmaceuticals in Q4 2021 and has held it in 15 quarters since.
- BTC Capital Management's ANI Pharmaceuticals position peaked at $702K in Q3 2025.
- 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.
Based on BTC Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.